Prophylactic central lymph node dissection in differentiated thyroid cancer

Endocrine

Volumn 44, Issue 2, 2013, Pages 275-277

  Goddard, Julie A ^a   Steward, David L ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; DIFFERENTIATED THYROID CANCER; EDITORIAL; HUMAN; HYPOPARATHYROIDISM; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MORBIDITY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RISK FACTOR; THYROIDECTOMY; VOCAL CORD PARALYSIS;

CARCINOMA; FEMALE; HUMANS; LYMPH NODE EXCISION; MALE; NEOPLASM RECURRENCE, LOCAL; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 84885585385     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-9975-1     Document Type: Editorial

References (11)

1. Conzo, G., Pasquali, D., Bellastella, G., Esposito, K., Carella, C., De Bellis, A., Docimo, G., Klain, M., Iorio, S., Napoliano, S., Palazzo, A., Pizza, A., Sinisi, A., Zampella, E., Bellastella, A., Santini, L., Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases. Endocrine (2012)
2. G.W. Randolph, Q. Duh, K.S. Heller, V.A. LiVolsi, S.J. Mandel, D.L. Steward, R.P. Tufano, R.M. Tuttle, For the American Thyroid Association Surgical Affairs Committee's Taskforce on Thyroid Cancer Nodal Surgery. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 22, 1144-1152 (2012)
3. W.T. Shen, L. Ogawa, D. Ruan, I. Suh, Q. Duh, O.H. Clark, Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgment in predicting which patients will benefit. Surgery 148, 398-403 (2010)
4. M. Sywak, L. Cornford, P. Roach, P. Stalberg, S. Sidhu, L. Delbridge, Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140, 1000-1007 (2006)
5. A. Popadich, O. Levin, J.C. Lee, S. Smooke-Praw, K. Ro, M. Fazel, A. Arora, N.S. Tolley, F. Palazzo, D.L. Learoyd, S. Sidhu, L. Delbridge, M. Sywak, M.W. Yeh, A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer. Surgery 150, 1048-1057 (2011)
6. D.T. Hughes, M.L. White, B.S. Miller, P.G. Gauger, R.E. Burney, G.M. Doherty, Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Surgery 148, 1100-1107 (2010)
7. M. Shindo, J. Wu, E.E. Park, F. Tanzella, The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer. Arch. Otolaryngol. Head Neck Surg. 132, 650-654 (2006)
8. S. Bonnet, D. Hartl, S. Leboulleux, E. Baudin, J.D. Lumbroso, A. Al Ghuzlan, L. Chami, M. Schlumberger, J.P. Travagli, Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: Implications for radioiodine treatment. J. Clin. Endocrinol. Metab. 94, 1162-1167 (2009)
9. D. Hartl, S. Leboulleux, A. Al Ghuzlan, E. Baudin, L. Chami, M. Schlumberger, J.P. Travagli, Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Ann. Surg. 255, 777-783 (2012)
10. T. Carling, S.E. Carty, M.M. Ciarleglio, D.S. Cooper, G.M. Doherty, L.T. Kim, R.T. Kloos, E.L. Mazzaferri Sr, P.N. Peduzzi, S.A. Roman, R.S. Sippel, J.A. Sosa, B.C. Stack, D.L. Steward, R.P. Tufano, R.M. Tuttle, R. Udelsman, for the American Thyroid Association Surgical Affairs Committee. American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma. Thyroid 22, 237-244 (2012)
11. L. Wartovsky, D. Van Nostrand, Radioiodine treatment of well-differentiated thyroid cancer. Endocrine 42, 506-513 (2012)